Introduction
This case highlights the journey of a 40-year-old homosexual male who presented with extensive anal warts following recovery from a viral illness. His initial symptoms were dismissed by his general practitioner (GP), prompting him to seek care at the London Skin Clinic. Subsequent investigations revealed an underlying diagnosis of leukemia, which was successfully treated with chemotherapy and stem cell transplantation. Preventive measures against anal cancer were implemented, and the patient achieved full recovery with no recurrence of leukemia or warts.
Case Presentation
A 40-year-old homosexual male, previously in good health, presented to the London Skin Clinic with a six-month history of florid, widespread anal warts. These lesions developed shortly after recovering from a viral illness. The patient described the warts as progressively increasing in size and number, causing discomfort and embarrassment. Despite visiting his GP, he reported receiving limited assistance, with topical treatments offering no relief. His primary concern was seeking an effective resolution for his symptoms, which were beginning to affect his mental well-being and quality of life.
The patient denied any significant past medical history and reported being otherwise well prior to the viral illness. He was in a monogamous relationship, with no history of other sexually transmitted infections (STIs). He was a non-smoker and consumed alcohol occasionally. His family history was non-contributory.
Examination and Management at London Skin Clinic
On examination, the patient had multiple verrucous lesions consistent with anal warts (condylomata acuminata), extending perianally and involving the anal canal. These were florid and appeared immune-mediated in nature, likely exacerbated by his recent viral illness. No other genital lesions or significant lymphadenopathy were noted.
The patient underwent cryotherapy as the first-line treatment. Cryotherapy was performed in multiple sessions over several weeks, targeting the warts effectively and minimizing discomfort. As part of the clinics protocol for high-risk patients, blood tests were conducted, including a full blood count (FBC) and screening for sexually transmitted infections.
Investigations
Blood test results revealed a significantly low white cell count (leukopenia) with a neutrophil predominance. Further hematological evaluation, including bone marrow biopsy, confirmed the diagnosis of acute myeloid leukemia (AML). No other systemic abnormalities were identified. The diagnosis of leukemia explained the patients susceptibility to viral illness and the immune dysregulation that contributed to the development of florid anal warts.
Treatment and Outcome
The patient was referred urgently to a hematology-oncology team for management of AML. He underwent induction chemotherapy followed by consolidation therapy. Subsequently, he received an allogeneic stem cell transplant, which achieved full remission of the leukemia.
During his cancer treatment, his anal warts regressed significantly, likely due to immune reconstitution following chemotherapy and transplantation. Post-recovery, the patient received the human papillomavirus (HPV) vaccine to protect against high-risk HPV types, reducing his risk of developing anal cancer in the future.
Follow-up at the London Skin Clinic showed no recurrence of anal warts. The patients immune system normalized following leukemia treatment, as evidenced by stable white cell counts on subsequent blood tests.
Discussion
This case underscores the importance of comprehensive care in patients presenting with anal warts, particularly in high-risk populations such as homosexual men. While anal warts are most commonly caused by HPV, their florid and widespread presentation can be a marker of underlying immunosuppression, warranting further investigation.
Leukopenia as a finding in this patient was critical in diagnosing acute myeloid leukemia. Early identification of hematological malignancies is vital for achieving positive outcomes. AML, if untreated, has a poor prognosis, but timely treatment with chemotherapy and stem cell transplantation offers the potential for cure, as seen in this patient.
The role of HPV vaccination in this case was pivotal. Men who have sex with men (MSM) are at increased risk of anal HPV infection and its sequelae, including anal cancer. Vaccination against HPV not only reduces the risk of recurrence of anal warts but also provides long-term protection against high-risk HPV types linked to cancer.
Conclusion
This case highlights the critical role of dermatological evaluation in identifying systemic conditions. The multidisciplinary approach involving dermatology, oncology, and hematology teams resulted in the successful treatment of both the patients AML and anal warts. Preventive measures, including HPV vaccination, further enhanced the patients prognosis.
The patient remains in full remission from leukemia and free of recurrent anal warts, emphasizing the importance of a thorough clinical assessment, timely investigation, and holistic care in achieving excellent outcomes.
Key Learning Points
1. Florid and widespread anal warts may indicate underlying immunosuppression and warrant further investigation.
2. Leukopenia should prompt consideration of hematological malignancies, particularly in high-risk individuals.
3. HPV vaccination is essential for preventing recurrence of anal warts and reducing the risk of anal cancer, especially in MSM populations.
4. Multidisciplinary care is crucial in managing complex cases involving dermatological and systemic conditions.
